|
Volumn 361, Issue 13, 2009, Pages 1313-1314
|
Clopidogrel plus aspirin in atrial fibrillation [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
ANTITHROMBOCYTIC AGENT;
DRUG DERIVATIVE;
TICLOPIDINE;
BLEEDING;
COMPARATIVE STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
HEALTH CARE COST;
HEART ATRIUM FIBRILLATION;
HUMAN;
LETTER;
PRIORITY JOURNAL;
QUALITY OF LIFE;
STROKE;
DRUG COMBINATION;
ECONOMICS;
NOTE;
QUALITY ADJUSTED LIFE YEAR;
RISK;
ASPIRIN;
ATRIAL FIBRILLATION;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
QUALITY-ADJUSTED LIFE YEARS;
RISK;
STROKE;
TICLOPIDINE;
|
EID: 70349449557
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (1)
|